ASTH β€” APOLLO MEDICAL HLDGS INC

Ownership history in PRELUDE CAPITAL MANAGEMENT, LLC  Β·  6 quarters on record

AI Ownership Summary

PRELUDE CAPITAL MANAGEMENT, LLC reported APOLLO MEDICAL HLDGS INC (ASTH) in 6 quarterly 13F filings from 2024 Q4 through 2025 Q3. Peak portfolio weight reached 0.03% in 2025 Q3. The latest visible filing shows ASTH at 0.03% of the fund.

This page tracks quarterly shares, estimated market value, portfolio weight, filing dates, and disclosure-aligned stock prices directly from SEC EDGAR 13F filings. Older history is available after unlock; the visible window still shows the most recent pattern.

What this ASTH ownership page tells you

This page is designed to answer the real investor question behind a 13F filing: how meaningful was PRELUDE CAPITAL MANAGEMENT, LLC's position in APOLLO MEDICAL HLDGS INC, and how did that conviction change over time? You can read the holding window, peak weight, latest reported size, disclosure timing, and quarter-by-quarter changes without piecing the story together from raw SEC rows.

Freshest filing
Latest Reported Filing
2025 Q3

ASTH was reported at 0.03% of portfolio in the most recent visible filing.

High-water mark
Peak Conviction
0.03% in 2025 Q3

Peak weight helps separate a token disclosure from a real conviction holding the fund genuinely cared about.

Time in book
Holding Window
2024 Q4 to 2025 Q3

Longer holding windows often tell a very different story from short-lived tactical trades or one-quarter experiments.

Decision context
Why It Matters
Position size beats headlines

Knowing that a fund owned a stock is useful. Knowing whether it was a 0.20% placeholder or a true high-conviction position is where the signal actually starts.

How PRELUDE CAPITAL MANAGEMENT, LLC held ASTH β€” position size vs. price
% of Fund (quarterly)    ASTH price (quarter-end, indexed to 100)
πŸ“‹ Quarterly Holdings History 2 quarters  β–Ύ
Quarter Action Shares Change Chg % % of Fund Mkt Value Filed Price (Filed)
2025 Q3 ADDED 12,382 +5,098 +70.0% 0.03% $351K 2025-11-14 $21.53
2024 Q4 REDUCED 7,284 -7,589 -51.0% 0.01% $230K 2025-02-14 $38.96
4 older quarters hidden  β€”  Sign in free or upgrade to Premium to see full history

FAQ About PRELUDE CAPITAL MANAGEMENT, LLC and ASTH

These are the practical questions this page is built to answer before you even open the full history table.

How long has PRELUDE CAPITAL MANAGEMENT, LLC reported owning ASTH?

PRELUDE CAPITAL MANAGEMENT, LLC reported ASTH across 2 quarterly 13F filings, from 2024 Q4 through 2025 Q3.

What was the largest reported ASTH position in PRELUDE CAPITAL MANAGEMENT, LLC's portfolio?

The largest reported portfolio weight for ASTH was 0.03% in 2025 Q3.

What is the latest reported ASTH position on this page?

The most recent filing on this page is 2025 Q3, when PRELUDE CAPITAL MANAGEMENT, LLC reported 12,382 shares, equal to 0.03% of portfolio, with an estimated market value of $351K.

What does the chart on this ASTH ownership page compare?

The chart compares PRELUDE CAPITAL MANAGEMENT, LLC's quarterly ASTH portfolio weight with the stock's indexed share price, so you can see whether the fund was building, trimming, or holding the position as price moved.

← Back to PRELUDE CAPITAL MANAGEMENT, LLC Holdings